These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17725905)

  • 21. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
    Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
    J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus.
    O'Neill SG; Pego-Reigosa JM; Hingorani AD; Bessant R; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2009 May; 48(5):573-5. PubMed ID: 19273540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reverse epidemiology in dialysis patients. The Danish Society of Nephrology].
    Dieperink H;
    Ugeskr Laeger; 2007 Mar; 169(12):1122. PubMed ID: 17394833
    [No Abstract]   [Full Text] [Related]  

  • 27. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients.
    Tsirpanlis G; Boufidou F; Zoga M; Triantafyllis G; Fatourou A; Stamatelou K; Bleta A; Petrihou C; Chatzipanagiotou S; Nicolaou C
    Hemodial Int; 2009 Apr; 13(2):197-204. PubMed ID: 19432694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute cardiovascular complications of hemodialysis.
    Coppolino G; Lucisano G; Bolignano D; Buemi M
    Minerva Urol Nefrol; 2010 Mar; 62(1):67-80. PubMed ID: 20424575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockade in chronic dialysis patients.
    Furgeson SB; Chonchol M
    Semin Dial; 2008; 21(1):43-8. PubMed ID: 18251957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
    Wan RK; Mark PB; Jardine AG
    Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.
    Shoji T; Tsubakihara Y; Nakai S; Nishizawa Y
    Nephrol Ther; 2008 Jul; 4(4):223-7. PubMed ID: 18406224
    [No Abstract]   [Full Text] [Related]  

  • 34. Is xerostomia a risk factor for cardiovascular morbidity and mortality in maintenance hemodialysis patients?
    Wilczynska-Borawska M; Baginska J; Borawski J
    Med Hypotheses; 2012 Oct; 79(4):544-8. PubMed ID: 22874451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic inflammation increases risk in hemodialysis patients.
    Razeghi E; Omati H; Maziar S; Khashayar P; Mahdavi-Mazdeh M
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):785-9. PubMed ID: 18711296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in traditional risk factors no longer explain time trends in cardiovascular mortality and its socioeconomic differences.
    Harald K; Koskinen S; Jousilahti P; Torppa J; Vartiainen E; Salomaa V
    J Epidemiol Community Health; 2008 Mar; 62(3):251-7. PubMed ID: 18272741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiological basis for risk factor reduction.
    Cunningham S; LaRosa JH; Hill MN; Becker DM
    Cardiovasc Nurs; 1988; 24(6):33-5. PubMed ID: 3060258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.